Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

Basit Öğe Kaydı
dc.contributor.authorSonmez, Alper
dc.contributor.authorHaymana, Cem
dc.contributor.authorBayram, Fahri
dc.contributor.authorSalman, Serpil
dc.contributor.authorDizdar, Oguzhan Sitki
dc.contributor.authorGurkan, Eren
dc.contributor.authorCarlioglu, Ayse Kargili
dc.date.accessioned2024-02-23T14:02:41Z
dc.date.available2024-02-23T14:02:41Z
dc.date.issued2018
dc.departmentNEÜen_US
dc.description.abstractAims: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. Methods: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c <7%, home arterial blood pressure (ABP) <135/85 mmHg, or LDL-C <100 mg/dL. Achieving all parameters indicated triple metabolic control. Results: HbA1c levels of patients (n = 5211) were 8.6 +/- 1.9% (71 +/- 22 mmol/mol) and 7.7 +/- 1.7% (61 +/- 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, nonsmoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. Conclusions: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease. (C) 2018 Elsevier B.V. All rights reserved.en_US
dc.description.sponsorshipTurkish Society of Endocrinology and Metabolismen_US
dc.description.sponsorshipThe TEMD study has been funded by the Turkish Society of Endocrinology and Metabolism. Automated blood pressure monitors were provided by Sanovel A/S. The funding agencies had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; or the preparation, review or approval of the manuscript.en_US
dc.identifier.doi10.1016/j.diabres.2018.09.010
dc.identifier.endpage147en_US
dc.identifier.issn0168-8227
dc.identifier.issn1872-8227
dc.identifier.pmid30244051en_US
dc.identifier.scopus2-s2.0-85057462824en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage138en_US
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2018.09.010
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11814
dc.identifier.volume146en_US
dc.identifier.wosWOS:000452704800016en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofDiabetes Research And Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectType 1 Diabetesen_US
dc.subjectType 2 Diabetesen_US
dc.subjectHba1cen_US
dc.subjectLdl-Cholesterolen_US
dc.subjectArterial Blood Pressureen_US
dc.titleTurkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu